Shoppers Drug Mart Corporation prices issuance of an aggregate of $500 million principal amount of Series 5 and Series 6 medium term notes


TORONTO, May 15, 2013 /CNW/ - Shoppers Drug Mart Corporation (TSX: SC) today announced that it has priced the issuance of $225 million aggregate principal amount of 2.01% unsecured medium term notes, Series 5, due May 24, 2016 for aggregate net proceeds of $224,392,500, as well as the issuance of $275 million aggregate principal amount of 2.36% unsecured medium term notes, Series 6, due May 24, 2018 for aggregate net proceeds of $273,933,000. The notes will be offered pursuant to pricing supplements to the Company's short form base shelf prospectus dated January 6, 2012. The pricing supplements will be filed with the securities regulatory authorities in each of the provinces of Canada. RBC Dominion Securities Inc., Scotia Capital Inc., CIBC World Markets Inc., TD Securities Inc., BMO Nesbitt Burns Inc., National Bank Financial Inc. and Desjardins Securities Inc. are acting as agents with respect to these offerings. The issuance of these notes is expected to close on or about May 21, 2013 and the net proceeds will be used to refinance existing indebtedness, including repayment of all amounts outstanding under the Company's $450 million aggregate principal amount of 4.99% unsecured medium term notes, Series 2, due June 3, 2013. As a result of using the net proceeds to refinance existing indebtedness, the consolidated net debt position of the Company is expected to remain substantially unchanged.

These offerings are only being made by way of prospectus. The pricing supplements and the short form base shelf prospectus, including the documents incorporated by reference therein, contain important information concerning these securities. Prospective investors should read the pricing supplements and the short form base shelf prospectus before making an investment decision.

This news release does not constitute an offer to sell or the solicitation of an offer to buy the securities in any jurisdiction. The securities being offered have not been approved or disapproved by any regulatory authority nor has any such authority passed upon the accuracy or adequacy of the pricing supplements or the short form base shelf prospectus.

The securities referred to herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any state securities laws and may not be offered, sold or delivered within the United States of America and its territories and possessions except in certain transactions exempt from such registration requirements.

Copies of the short form base shelf prospectus and the pricing supplements relating to the offering of these securities may be obtained from SEDAR at

About Shoppers Drug Mart Corporation

Shoppers Drug Mart Corporation is one of the most recognized and trusted names in Canadian retailing. The Company is the licensor of full-service retail drug stores operating under the name Shoppers Drug Mart (Pharmaprix in Québec). With more than 1,240 Shoppers Drug Mart and Pharmaprix stores operating in prime locations in each province and two territories, the Company is one of the most convenient retailers in Canada. The Company also licenses or owns 59 medical clinic pharmacies operating under the name Shoppers Simply Pharmacy (Pharmaprix Simplement Santé in Québec) and six luxury beauty destinations operating as Murale. As well, the Company owns and operates 62 Shoppers Home Health Care stores, making it the largest Canadian retailer of home health care products and services. In addition to its retail store network, the Company owns Shoppers Drug Mart Specialty Health Network Inc., a provider of specialty drug distribution, pharmacy and comprehensive patient support services; and MediSystem Technologies Inc., a provider of pharmaceutical products and services to long-term care facilities.

Additional information about the Company can be found at


SOURCE: Shoppers Drug Mart Corporation

For further information:

Media Contact:
Tammy Smitham
Vice President, Communications & Corporate Affairs
(416) 490-2892

Investor Relations:
(416) 493-1220, ext. 5678


Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .


Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.


Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.